CN Stock MarketDetailed Quotes

300363 Porton Pharma Solutions

Watchlist
  • 16.46
  • -0.02-0.12%
Market to Open Dec 27 09:30 CST
8.98BMarket Cap-22.92P/E (TTM)

Porton Pharma Solutions Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Porton Pharma Solutions Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2674.364M / 1.118B--
--2024/Q1677.718M / 653.000M--
--2023/Q4630.414M / 621.000M--
--2023/Q3698.257M / 796.000M--
--2023/Q2960.944M / 1.256B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2674.364M / 1.118B--
--2024/Q1677.718M / 653.000M--
--2023/Q4630.414M / 621.000M--
--2023/Q3698.257M / 796.000M--
--2023/Q2960.944M / 1.256B--

Unlock Free Earnings Estimates

Porton Pharma Solutions Earnings Reports

  • Boteng shares: 2024 third quarter report

    Oct 24 12:00 ET

  • Boteng shares: 2024 semi-annual report

    Aug 27 12:00 ET

  • Boteng Shares: 2024 Semi-Annual Report Summary

    Aug 27 12:00 ET

  • Porton Pharma Solutions: 2024 First Quarter Report

    Apr 26 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 26, 2024

    Strong Buy

    • Strong Buy

      78.57%

    • Buy

      21.43%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data